New ERN ReCONNET webinar is scheduled for this week, on April 17th at 4pm! 💡Topic will be disease specific, targeting audience will be healthcare professionals (HCPs). Guest speaker will be Prof. Laurent Arnaud from the Service de Rhumatologie, Hôpitaux Universitaires de Strasbourg, Centre National de Référence des Maladies Auto-Immunes Est Sud-Ouest (RESO), Strasbourg (France). Prof. Arnaud is our Disease coordinator for Relapsing Polychondritis (RP). The webinar is focused on the French practical guidelines for the diagnosis and management of RP. RP usually begins in middle-aged individuals. This diagnosis is mainly suggested in the presence of chondritis, i.e. inflammatory flares on the cartilage, in particular of the ears, nose or respiratory tract, and more rarely in the presence of other manifestations. The formal diagnosis of relapsing polychondritis cannot be established with certainty before the onset of chondritis, which can sometimes occur several years after the first signs. No laboratory test is specific of relapsing polychondritis, the diagnosis is usually based on clinical evidence and the elimination of differential diagnoses. ✍ Registration is open and free at this link: bit.ly/49wNcYR ⚙️ More RP resources, info, and links can be found here: bit.ly/3sxN37s
ERN ReCONNET’s Post
More Relevant Posts
-
Insightful information from Dr. Blitz. Knowledge is empowering.
Developmental Pediatrician and Senior Medical Director, Special Needs Initiative of UnitedHealthcare
Blitz Blog – This week is Rare Disease Week Welcome back to the Blitz Blog. Today, we have a guest writer – Debra Hanley, one of our fabulous UHC Special Needs Family Engagement Center (FEC)’s Care Advisors. Please read on to learn more about Rare Disease Week from Debra. Many of our UHC members served by the FEC are affected by a rare disease. Rare Disease Week, held on the last week of February each year, is the lead into World Rare Disease Day (February 29th). It is an annual observance to raise awareness for 300 million people affected by rare disease globally. February was picked for this observance because it is the rarest among months – it is the only month that does not have 30 or 31 days. In most years, World Rare Disease Day falls on February 28th, but this year, a Leap Year, it is on February 29th. It’s extra rare. The #ICareAboutRare campaign features a picture of a zebra. Why the zebra? “When you hear the sound of hooves, think horses, not zebras.” This phrase is taught to medical students throughout their training. In medicine, the term “zebra” is used in reference to a rare disease or condition. Doctors are taught to assume that the simplest explanation is usually correct to avoid patients being misdiagnosed with rare illnesses. Doctors learn to expect common conditions. But many medical professionals seem to forget that “zebras” DO exist and so getting a diagnosis and treatment can be more difficult for sufferers of rare conditions. Rare Disease Facts: RARE Disease Facts - Global Genes https://lnkd.in/g-DUiAHQ For more information: - Sometimes It’s a Zebra — Rare Genomics Institute - Resources Archive - National Organization for Rare Disorders (rarediseases.org) - Rare Disease Day 2024 - Join Us On February 29 | NORD (rarediseases.org) - Rare Diseases Deserve Our Attention (nichq.org) - Rare Disease Day 2024 - https://lnkd.in/gZCf6eTv - https://globalgenes.org/ Happy reading and learning! #RareDiseaseWeek #WorldRareDiseaseDay #ICareAboutRare
To view or add a comment, sign in
-
Blitz Blog – This week is Rare Disease Week Welcome back to the Blitz Blog. Today, we have a guest writer – Debra Hanley, one of our fabulous UHC Special Needs Family Engagement Center (FEC)’s Care Advisors. Please read on to learn more about Rare Disease Week from Debra. Many of our UHC members served by the FEC are affected by a rare disease. Rare Disease Week, held on the last week of February each year, is the lead into World Rare Disease Day (February 29th). It is an annual observance to raise awareness for 300 million people affected by rare disease globally. February was picked for this observance because it is the rarest among months – it is the only month that does not have 30 or 31 days. In most years, World Rare Disease Day falls on February 28th, but this year, a Leap Year, it is on February 29th. It’s extra rare. The #ICareAboutRare campaign features a picture of a zebra. Why the zebra? “When you hear the sound of hooves, think horses, not zebras.” This phrase is taught to medical students throughout their training. In medicine, the term “zebra” is used in reference to a rare disease or condition. Doctors are taught to assume that the simplest explanation is usually correct to avoid patients being misdiagnosed with rare illnesses. Doctors learn to expect common conditions. But many medical professionals seem to forget that “zebras” DO exist and so getting a diagnosis and treatment can be more difficult for sufferers of rare conditions. Rare Disease Facts: RARE Disease Facts - Global Genes https://lnkd.in/g-DUiAHQ For more information: - Sometimes It’s a Zebra — Rare Genomics Institute - Resources Archive - National Organization for Rare Disorders (rarediseases.org) - Rare Disease Day 2024 - Join Us On February 29 | NORD (rarediseases.org) - Rare Diseases Deserve Our Attention (nichq.org) - Rare Disease Day 2024 - https://lnkd.in/gZCf6eTv - https://globalgenes.org/ Happy reading and learning! #RareDiseaseWeek #WorldRareDiseaseDay #ICareAboutRare
NORD Rare Diseases – National Organization for Rare Disorders
https://rarediseases.org
To view or add a comment, sign in
-
📃Scientific paper: Rare complication of four extremity compartment syndrome requiring fasciotomy from influenza A viral myositis Ref.: BMJ Publishing Group, 2021 Abstract: Influenza A and B commonly cause benign respiratory disease in humans, but can cause more severe illness in high-risk populations. We report an unusual case of a previously healthy adult patient who presented with myositis and severe rhabdomyolysis secondary to influenza A infection that resulted in atraumatic compartment syndrome of all four extremities, each requiring emergent fasciotomy. The patient was subsequently managed with delayed primary closure and skin grafting in the operating room. Prompt recognition of this rare complication by the team resulted in no limb amputations. On his first follow-up appointment, 1 month after discharge, he had regained full functionality in both his hands and his feet were both close to 50% of baseline and improving with physical therapy. Continued on ES/IODE ➡️ https://etcse.fr/51tPH ------- If you find this interesting, feel free to follow, comment and share. We need your help to enhance our visibility, so that our platform continues to serve you.
Rare complication of four extremity compartment syndrome requiring fasciotomy from influenza A viral myositis
ethicseido.com
To view or add a comment, sign in
-
Our newly published paper! This systematic review summarized the evidence (2013-2022) on the costs of COPD and post-TB sequelae in LMICs. The data are presented as a Cost Database of COPD and Post-TB (CD-CPTB) in an open access online GitHub repository for any further analysis of interested researchers.
I am very excited to share this just-published paper I collaborated on when working at the Swiss Tropical and Public Health Institute with Yuling Lin Alexandra Walker Marguerite Batta Anna Duchenkon Curdin Brugger Keiser Olivia Robert S Wallis, MD, FIDSA, FRCP(E) Klaus Reither Fabrizio Tediosi and Marina Antillon 🎉 "Economic burden of chronic obstructive pulmonary disease and post-tuberculosis sequelae in low- and middle-income countries: a database compiled from a systematic review and meta-analysis" Read it here: https://lnkd.in/er4p7VQF
Economic burden of chronic obstructive pulmonary disease and post-tuberculosis sequelae in low- and middle-income countries: a database compiled from a systematic review and meta-analysis
bmjpublichealth.bmj.com
To view or add a comment, sign in
-
We're excited to invite you to an exclusive live webinar hosted by Borland Groover's renowned Gastroenterologist, Dr. Kapila, on August 15th. This is your opportunity to gain valuable insights into Fatty Liver Disease from one of the leading experts in the field. Why Attend Our Webinar? 1. Expert Insights: Learn about the risk factors for Fatty Liver Disease and how they may affect you. 2. Personalized Information: Understand your specific risk factors, especially if you have high cholesterol, obesity, high triglycerides, or Type 2 Diabetes. 3. Interactive Session: Have your questions answered in real-time during our Q&A session. 4. Actionable Advice: Receive practical tips on managing and reducing your risk for Fatty Liver Disease through lifestyle changes and medical interventions. Who Should Attend? • Individuals diagnosed with Fatty Liver Disease. • Those with high cholesterol or high triglycerides. • Individuals struggling with obesity. • Patients with Type 2 Diabetes. • Anyone concerned about their liver health and looking for preventive measures. Register at EBGCR.COM/FATTYLIVER
To view or add a comment, sign in
-
#CVCT2024 : Back from the Seventh World Symposium on Pulmonary Hypertension: when the Global CVCT Forum hosts pulmonary hypertension trialists. Since 1960, pulmonary hypertension has been the focus of WHO Committee reports and World Symposia proceedings. The seventh World Symposium has just been held in Barcelona, Spain, on June 27-July 1st 2024. It is thus very timely to share and debate the conclusions of this major event at the 21st Global CVCT Forum. Three sessions will offer challenging discussion on pulmonary arterial hypertension clinical trial design, intersection with heart failure in pulmonary hypertension associated with left heart failure and new frontiers in pulmonary hypertension associated with chronic lung diseases. Join Milton Packer, Olivier SITBON, Guillermo Bortman PHMD, Steven Kawut, Jason Weatherald, Sanjiv Shah and many others, December 9-11, 2024, Washington DC. Full program here : https://lnkd.in/dXSEJhZB #clinicaltrials #clinicalresearch #pulmonaryhypertension
To view or add a comment, sign in
-
💗 Interested in #cardiovascular risk in #rheumatology? Experience in #inflammatory diseases? We need your input in a quick survey (under 10 minutes!) on awareness of guidelines for inflammatory rheumatic diseases and their cardiovascular risks. Conducted by the CVIIA study group with the Danish Centre for Excellence in Rheumatology, this survey will help us understand how well the EULAR guidelines are known and identify barriers to clinical implementation. Your participation not only helps improve patient care but also supports the important work of CVIIA. 🙌 📩 Please take a moment to complete the survey and feel free to share it with your colleagues! 🔗 https://lnkd.in/eSaAaHkq
To view or add a comment, sign in
-
📃Scientific paper: Rare complication of four extremity compartment syndrome requiring fasciotomy from influenza A viral myositis Abstract: Influenza A and B commonly cause benign respiratory disease in humans, but can cause more severe illness in high-risk populations. We report an unusual case of a previously healthy adult patient who presented with myositis and severe rhabdomyolysis secondary to influenza A infection that resulted in atraumatic compartment syndrome of all four extremities, each requiring emergent fasciotomy. The patient was subsequently managed with delayed primary closure and skin grafting in the operating room. Prompt recognition of this rare complication by the team resulted in no limb amputations. On his first follow-up appointment, 1 month after discharge, he had regained full functionality in both his hands and his feet were both close to 50% of baseline and improving with physical therapy. Continued on ES/IODE ➡️ https://etcse.fr/51tPH ------- If you find this interesting, feel free to follow, comment and share. We need your help to enhance our visibility, so that our platform continues to serve you.
Rare complication of four extremity compartment syndrome requiring fasciotomy from influenza A viral myositis
ethicseido.com
To view or add a comment, sign in
-
📃Scientific paper: Rare complication of four extremity compartment syndrome requiring fasciotomy from influenza A viral myositis Abstract: Influenza A and B commonly cause benign respiratory disease in humans, but can cause more severe illness in high-risk populations. We report an unusual case of a previously healthy adult patient who presented with myositis and severe rhabdomyolysis secondary to influenza A infection that resulted in atraumatic compartment syndrome of all four extremities, each requiring emergent fasciotomy. The patient was subsequently managed with delayed primary closure and skin grafting in the operating room. Prompt recognition of this rare complication by the team resulted in no limb amputations. On his first follow-up appointment, 1 month after discharge, he had regained full functionality in both his hands and his feet were both close to 50% of baseline and improving with physical therapy. Continued on ES/IODE ➡️ https://etcse.fr/51tPH ------- If you find this interesting, feel free to follow, comment and share. We need your help to enhance our visibility, so that our platform continues to serve you.
Rare complication of four extremity compartment syndrome requiring fasciotomy from influenza A viral myositis
ethicseido.com
To view or add a comment, sign in
-
The ability to breathe easily – how many of us take it for granted? For people living with respiratory diseases like COPD or asthma, it’s often not that simple. That’s why we’re using our expertise in immunology and inflammation to work toward advancing diverse treatment options for patients. This week at American Thoracic Society Conference, we came together with industry experts to unlock the science and deepen our understanding of what’s driving these diseases and how we can help. I left these conversations inspired not only by the insights, but more so by the patients for whom we #neversettle. Learn more: https://lnkd.in/d_-MY3NM
Every Breath Matters: Addressing Unmet Needs in Respiratory Care
sanofi.com
To view or add a comment, sign in
684 followers